ZA200907415B - Triazol compounds for treating biofilm formation - Google Patents

Triazol compounds for treating biofilm formation

Info

Publication number
ZA200907415B
ZA200907415B ZA200907415A ZA200907415A ZA200907415B ZA 200907415 B ZA200907415 B ZA 200907415B ZA 200907415 A ZA200907415 A ZA 200907415A ZA 200907415 A ZA200907415 A ZA 200907415A ZA 200907415 B ZA200907415 B ZA 200907415B
Authority
ZA
South Africa
Prior art keywords
biofilm formation
treating biofilm
triazol compounds
triazol
compounds
Prior art date
Application number
ZA200907415A
Other languages
English (en)
Inventor
David Reid
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38534753&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200907415(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200907415B publication Critical patent/ZA200907415B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200907415A 2007-05-22 2009-10-22 Triazol compounds for treating biofilm formation ZA200907415B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07108650A EP1994930A1 (en) 2007-05-22 2007-05-22 Triazol compounds for treating biofilm formation

Publications (1)

Publication Number Publication Date
ZA200907415B true ZA200907415B (en) 2010-07-28

Family

ID=38534753

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200907415A ZA200907415B (en) 2007-05-22 2009-10-22 Triazol compounds for treating biofilm formation

Country Status (18)

Country Link
US (2) US8309590B2 (enExample)
EP (3) EP1994930A1 (enExample)
JP (1) JP5470245B2 (enExample)
KR (1) KR101519675B1 (enExample)
CN (2) CN101678004A (enExample)
AU (1) AU2008252964B2 (enExample)
BR (1) BRPI0811103A2 (enExample)
CA (1) CA2685112A1 (enExample)
CL (1) CL2008001469A1 (enExample)
IL (1) IL201832A (enExample)
MA (1) MA31388B1 (enExample)
MX (1) MX2009012628A (enExample)
NZ (1) NZ580735A (enExample)
RU (1) RU2478385C2 (enExample)
TN (1) TN2009000487A1 (enExample)
TW (1) TWI419690B (enExample)
WO (1) WO2008142094A1 (enExample)
ZA (1) ZA200907415B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8829198B2 (en) 2007-10-31 2014-09-09 Proteotech Inc Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
EP1994930A1 (en) * 2007-05-22 2008-11-26 Novartis AG Triazol compounds for treating biofilm formation
WO2009111611A2 (en) 2008-03-05 2009-09-11 Proteotech Inc. Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
GB201021186D0 (en) * 2010-12-14 2011-01-26 Novabiotics Ltd Composition
TWI415572B (zh) 2011-06-17 2013-11-21 Univ Chang Gung 利用１，２，３，４，６－五－ｏ－沒食子醯基－ｄ－葡哌喃糖來抑制生物膜形成
WO2017015352A1 (en) * 2015-07-22 2017-01-26 Ohio State Innovation Foundation Compositions and methods for inhibiting the growth of multi-drug resistant microbes
RU2646488C2 (ru) * 2016-04-25 2018-03-05 Государственное бюджетное образовательное учреждение высшего профессионального образования "Оренбургский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО ОрГМУ Минздрава России) Средство для селективного влияния на биопленкообразование микроорганизмами
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN110448693A (zh) * 2019-07-30 2019-11-15 华东理工大学 氟喹诺酮类药物作为多粘菌素类抗生素增敏剂的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004438A (en) * 1991-12-31 1999-12-21 3M Innovative Properties Company Biofilm reduction sterilizer
IL112778A0 (en) * 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
MY129541A (en) * 1996-06-25 2007-04-30 Novartis Ag Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
AU3191597A (en) * 1996-06-26 1998-01-14 Sankyo Company Limited Novel medicinal compositions of hydropyridines
US6759040B1 (en) * 1997-09-12 2004-07-06 University Of Maryland, College Park Preparation and use of biofilm-degrading, multiple-specificity, hydrolytic enzyme mixtures
EP1296688A2 (en) * 2000-03-23 2003-04-02 Influx, Inc. Bactericidal antimicrobial methods and compositions for use in treating gram positive infections comprising an antibiotic potentiator having acyl hydrazide, oxy amide or 8-hydroxy quinoline structure
AU2002254342A1 (en) * 2001-03-23 2002-10-08 The Board Of Trustees Of The University Of Illinois Compounds capable of modulating the activity of multidrug transporters and therapeutic use of the same
GB0126618D0 (en) * 2001-11-06 2002-01-02 Novartis Ag Organic compounds
GB0205593D0 (en) 2002-03-09 2002-04-24 Univ Nottingham Treatment of surfaces populated by bacteria
CN101134119A (zh) * 2002-05-24 2008-03-05 血管技术国际股份公司 用于涂覆医用植入物的组合物和方法
US7498292B2 (en) * 2002-08-15 2009-03-03 The Research Foundation Of State University Of New York Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
GB0223978D0 (en) 2002-10-15 2002-11-20 Novartis Ag Organic compound
EP1994930A1 (en) * 2007-05-22 2008-11-26 Novartis AG Triazol compounds for treating biofilm formation

Also Published As

Publication number Publication date
RU2009147297A (ru) 2011-06-27
TW200913996A (en) 2009-04-01
US20120329746A1 (en) 2012-12-27
CN101678004A (zh) 2010-03-24
US8592473B2 (en) 2013-11-26
JP5470245B2 (ja) 2014-04-16
US20100152101A1 (en) 2010-06-17
CL2008001469A1 (es) 2010-10-29
CA2685112A1 (en) 2008-11-27
NZ580735A (en) 2012-02-24
EP2162130A1 (en) 2010-03-17
AU2008252964B2 (en) 2011-12-01
MX2009012628A (es) 2009-12-07
AU2008252964A1 (en) 2008-11-27
JP2010527960A (ja) 2010-08-19
RU2478385C2 (ru) 2013-04-10
KR20100017153A (ko) 2010-02-16
BRPI0811103A2 (pt) 2014-12-09
WO2008142094A4 (en) 2009-01-29
KR101519675B1 (ko) 2015-05-12
IL201832A0 (en) 2010-06-16
EP2253317A2 (en) 2010-11-24
TWI419690B (zh) 2013-12-21
CN103381271A (zh) 2013-11-06
EP2253317A3 (en) 2011-03-16
TN2009000487A1 (en) 2011-03-31
MA31388B1 (fr) 2010-05-03
EP1994930A1 (en) 2008-11-26
IL201832A (en) 2015-11-30
WO2008142094A1 (en) 2008-11-27
US8309590B2 (en) 2012-11-13

Similar Documents

Publication Publication Date Title
IL257418A (en) Methods for treating addiction
IL209895A0 (en) Compounds for treating beta-amyloidoses
IL201832A0 (en) Triazol compounds for treating biofilm formation
EP2175851A4 (en) TREATMENT OF BIOFILM
IL209894A0 (en) Compounds for treating amyloidoses
ZA200908898B (en) Dentifruce compositions for treating xerostomia
AP2010005163A0 (en) Substituted bicyclolactam compounds
ZA201109031B (en) Compounds useful for treating aids
ZA201103946B (en) Compounds useful for inhibiting chk1
GB0704394D0 (en) Compounds
IL213398A0 (en) Compounds for treating cancer
GB0705672D0 (en) Compounds
IL212212A0 (en) Compound useful for treating cellulite
GB0614070D0 (en) Compounds
ZA200903242B (en) Treatment for multiple myeloma
HK1141246A (en) Triazol compounds for treating biofilm formation
AP2010005225A0 (en) Process for treating sulphatecontaining effluent
GB0701955D0 (en) Compounds
GB0701985D0 (en) Compounds
ZA201000867B (en) Methods for treating dependence
HK1152471A (en) Compounds for treating amyloidoses
GB0701984D0 (en) Compounds
GB0701986D0 (en) Compounds
GB0701956D0 (en) Compounds
GB0700287D0 (en) Compounds